Mount Sinai Uses Remote Patient Monitoring to Rapidly Respond to COVID-19

Newswise — A new remote monitoring platform developed by the Mount Sinai Health System is helping health care providers to care for COVID-19 patients who are recovering at home. With the platform, providers can monitor the patients’ symptoms and adjust care as necessary, including sending the patient to the hospital if symptoms worsen.

The platform was originally developed for stroke patients by Christopher Kellner, MD, and David Putrino, PhD, Co-Directors of Mount Sinai’s Precision Recovery Platform. When the COVID-19 outbreak began, Drs. Kellner and Putrino quickly repurposed it to address the large number of patients with confirmed or suspected COVID-19 whose symptoms are not severe enough to need hospitalization.

The COVID-19 version of the platform launched early last week and has already enrolled hundreds of patients.

“Technology has a massive role to play in this major health care crisis,” said Dr. Kellner, an Assistant Professor of Neurosurgery at the Icahn School of Medicine at Mount Sinai and Director of the Intracerebral Hemorrhage Program. “And with remote monitoring of COVID-19, we can save hospital resources for the patients who need them most, but also quickly triage patients if and when they begin to show more severe symptoms while they are being monitored at home.”

Dr. Putrino, an Assistant Professor of Rehabilitation and Human Performance at the Icahn School of Medicine at Mount Sinai and Co-Director of the Abilities Research Center at Mount Sinai, said, “At the same time, we can also continue to provide vulnerable patients with excellent routine care, keep them out of the hospital, and shield them from additional exposure to the virus. We are saving lives.”

How Does It Work?

A patient can enroll in the program by a Mount Sinai Health System physician or the patient can text the words "Precision Recovery" to (332) 213-9130. A Mount Sinai provider from the Precision Recovery team will then contact them as soon as possible to establish an online video chat for on-boarding. As part of the on-boarding, the patient downloads a daily symptom tracking application, MyCap, which is completed via smart device to help the team track symptoms of the virus, such as body temperature, cough, breathing levels, and body aches. If a health care provider on the team sees concerning data during the home monitoring, the provider can enlist one of the Mount Sinai doctors on the team to have an online video chat with the patient. If necessary, they can organize an emergency medical team for mobilization. The program has escalated a handful of patients to the hospital so far. According to Drs. Kellner and Putrino, Precision Recovery has the capacity to help thousands more. To learn more about the program go to https://precisionrecovery.net/ 

About the Mount Sinai Health System

The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty and our physicians in the top 1% of all physicians nationally by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

 




Filters close

Showing results

110 of 1996
Newswise: Daya Bay Reactor Experiment Continues to Generate Data
Released: 29-May-2020 10:00 AM EDT
Daya Bay Reactor Experiment Continues to Generate Data
Lawrence Berkeley National Laboratory

Largely unaffected by the pandemic, the Daya Bay reactor neutrino experiment in Shenzen, China, has continued to pump data to remote supercomputers for analyses.

Newswise:Video Embedded newswise-expert-panels-on-covid-19-pandemic-notable-excerpts-quotes-and-videos-available
VIDEO
Released: 29-May-2020 9:50 AM EDT
Newswise Expert Panels on COVID-19 Pandemic: Notable excerpts, quotes and videos available
Newswise

Newswise is hosting a series of Expert Panels discussion unique aspects of the COVID-19 Outbreak. This tip sheet includes some notable quotes from the panelists.

Newswise: COVID-19 Healthcare Coalition Launches COVID-19 Decision Support Dashboard
Released: 29-May-2020 9:00 AM EDT
COVID-19 Healthcare Coalition Launches COVID-19 Decision Support Dashboard
COVID-19 Healthcare Coalition

The new COVID-19 Decision Support Dashboard synthesizes large amounts of complex, essential data into easy-to-use key findings for public and private-sector leaders navigating the “reopening” of communities and businesses.

Released: 29-May-2020 9:00 AM EDT
Online, or On-Campus? Returning to School After COVID: Newswise Live Event for June 4, 2PM EDT
Newswise

Will schools reopen in the fall? If schools remain closed, what will be the impact on students’ education, long-term? How has the pandemic already impacted students, from elementary through higher ed; how are schools at all levels adapting to teaching virtually, and how to safely return to teaching in person - June 4, 2020 from 2-3 PM EDT

Released: 29-May-2020 6:50 AM EDT
Those with IDD more likely to die from COVID-19, study shows
Syracuse University

A new study published recently in ScienceDirect by researchers from Syracuse University and SUNY Upstate Medical University shows that people with intellectual and developmental disabilities (IDD) are more likely to die from COVID-19 than those without IDD.

Newswise: Invention by a Finnish start-up speeds up coronavirus testing
Released: 29-May-2020 6:25 AM EDT
Invention by a Finnish start-up speeds up coronavirus testing
Aalto University

An Aalto University spinoff company has come up with a way to use existing lab microscopes in a completely new and much more effective way with their innovation of nanocoated glass. While this is very relevant to covid19 research, it holds great promise for many other viruses and diseases

Newswise: Tourism: what’s our new normal?
Released: 29-May-2020 6:20 AM EDT
Tourism: what’s our new normal?
University of South Australia

After months of lockdown, it’s no surprise that people are itching to get out and about. But with ongoing debates about how and when to open Australia’s state and territory borders, it’s hard to know what to expect.

Newswise: Calibrated approach to AI and deep learning models could more reliably diagnose and treat disease
Released: 29-May-2020 6:05 AM EDT
Calibrated approach to AI and deep learning models could more reliably diagnose and treat disease
Lawrence Livermore National Laboratory

In a recent preprint (available through Cornell University’s open access website arXiv), a team led by a Lawrence Livermore National Laboratory computer scientist proposes a novel deep learning approach aimed at improving the reliability of classifier models designed for predicting disease types from diagnostic images, with an additional goal of enabling interpretability by a medical expert without sacrificing accuracy. The approach uses a concept called confidence calibration, which systematically adjusts the model’s predictions to match the human expert’s expectations in the real world.

Newswise: Researchers Develop Experimental Rapid COVID-19 Test Using Innovative Nanoparticle Technique
Released: 28-May-2020 6:35 PM EDT
Researchers Develop Experimental Rapid COVID-19 Test Using Innovative Nanoparticle Technique
University of Maryland Medical Center

Scientists from the University of Maryland School of Medicine (UMSOM) developed an experimental diagnostic test for COVID-19 that can visually detect the presence of the virus in 10 minutes. It uses a simple assay containing plasmonic gold nanoparticles to detect a color change when the virus is present. The test does not require the use of any advanced laboratory techniques, such as those commonly used to amplify DNA, for analysis. The authors published their work last week in the American Chemical Society’s nanotechnology journal ACS Nano.


Showing results

110 of 1996

close
1.21189